Results 221 to 230 of about 99,765 (284)

Rhinovirus in Adults With Severe Lower Respiratory Tract Infection: Incidental Carriage or Primary Pathogen? A Comparative Study Across Different Clinical Status Categories

open access: yesTropical Medicine &International Health, EarlyView.
ABSTRACT Background Rhinovirus (RV) is a recognized respiratory pathogen, but its role in severe lower respiratory tract infections (LRTI) in adults remains debated. The aim of the study was to investigate RV in different clinical status categories at Hospital Sao Paulo, a tertiary facility in Sao Paulo, Brazil.
Ana Helena Perosa   +4 more
wiley   +1 more source

Prevention and treatment of post‐endoscopic retrograde cholangiopancreatography cholangitis: Current evidence and future directions

open access: yesClinical and Translational Discovery, Volume 6, Issue 6, December 2026.
1. Prevention strategies should be stratified by preoperative cholangitis status. 2. For pre‐existing cholangitis, therapeutic antibiotics plus urgent drainage are essential; ENBD and stents show similar efficacy. 3. Early biliary drainage is the cornerstone of treatment; endoscopic drainage is preferred, with PTCD/EUS‐BD as second‐line. 4.
Hao‐Xin Chen, Jun Yao
wiley   +1 more source

Endotoxins and Biological Implications—Review

open access: yesPublic Health Challenges, Volume 5, Issue 4, December 2026.
Graphical overview of endotoxin sources, exposure routes, biological effects, detection methods, and routes of elimination. ABSTRACT Endotoxins, also known as lipopolysaccharides (LPSs), are structural components of the outer membrane of Gram‐negative bacteria and some cyanobacteria.
Uzair Ishtiaq   +5 more
wiley   +1 more source

Nasopharyngeal carriage rate, serotype distribution, and antimicrobial profiles of Streptococcus pneumoniae among patients with acute respiratory tract infection in Manado, North Sulawesi, Indonesia. [PDF]

open access: yesAccess Microbiol
Purwanto DS   +10 more
europepmc   +1 more source

Prevalence of SARS‐CoV2 in Communities Surrounding Bwindi–Mgahinga Mountain Gorilla Conservation Area, Uganda

open access: yesPublic Health Challenges, Volume 5, Issue 4, December 2026.
COVID‐19 threatens endangered mountain gorilla populations due to close human contact. A cross‐sectional study (n = 576) in communities around Bwindi–Mgahinga Conservation Area found 8.0% prevalence of SARS‐CoV2. Frequent handwashing was a predictor for reduced prevalence of SARS‐CoV2. Strengthening prevention measures is critical to limit transmission
Joseph M. Kungu   +7 more
wiley   +1 more source

Prevalence and serotype distribution of nasopharyngeal carriage of Streptococcus pneumoniae among healthy children under 5 years of age in Hainan Province, China. [PDF]

open access: yesInfect Dis Poverty
Wang J   +16 more
europepmc   +1 more source

Poorly differentiated lung adenocarcinomas with concurrent ALK and CD30 expression: a diagnostic pitfall mimicking ALK‐positive anaplastic large‐cell lymphoma

open access: yesHistopathology, Volume 89, Issue 6, Page 1031-1041, December 2026.
Poorly differentiated lung adenocarcinomas with concurrent anaplastic lymphoma kinase (ALK) and CD30 expression closely mimic ALK‐positive anaplastic large‐cell lymphoma, creating a significant diagnostic pitfall. Accurate classification requires comprehensive integration of clinical, radiologic, morphologic, immunophenotypic and molecular findings ...
Jietian Jin   +6 more
wiley   +1 more source

A PD1‐CD137L Fusion Protein More Potently Enhances Anti‐Tumour Immune Responses Than Targeting PD‐L1 and CD137 Separately

open access: yesImmunology, Volume 179, Issue 4, Page 579-593, December 2026.
A PD1‐CD137L fusion protein converts the immunoinhibitory PD‐L1 to an immunostimulatory signal and is more effective than targeting PD‐L1 and CD137 separately. ABSTRACT Tumour immune evasion frequently involves PD‐L1‐mediated inhibition of T cell activity, limiting the efficacy of PD1/PD‐L1 blockade, particularly in PD‐L1‐low or immunologically ‘cold ...
Runze Xia   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy